首页> 外国专利> STEREOSELECTIVE MICROBIAL REDUCTION FOR THE PREPARATION OF 1-(4-FLUOROPHENYL)-3(R)-3(S)-HYDROXY-3-(4-FLUOROPHENYL)PROPYL)-4(S)-(4-HYDROXYPHENYL)-2-AZETIDINONE

STEREOSELECTIVE MICROBIAL REDUCTION FOR THE PREPARATION OF 1-(4-FLUOROPHENYL)-3(R)-3(S)-HYDROXY-3-(4-FLUOROPHENYL)PROPYL)-4(S)-(4-HYDROXYPHENYL)-2-AZETIDINONE

机译:用于制备1-(4-氟代苯基)-3(R)-[3(S)-羟基-3-(4-氟代苯基)丙基)]-4(S)-(4-羟基苯基)-的立体选择性微生物还原2-氮杂环丁酮

摘要

A process for the stereoselective microbial reduction of compound of formula(II) to compound of formula (I) comprising addingcompound of formula (II) to a medium, medium and buffer, medium and solvent,or medium and a mixture of buffer and solvent containinga microorganism, preferably Rhodococcus fascians ATCC No.202210 or fungalisolate Geotrichum candidum ATCC No. 74487, incubatingthe resulting mixture, and isolating a hydroxy compound of formula (I), isdescribed. The compound of formula (I) is a serum cholesterollowering agent.
机译:立体选择性还原式的化合物的方法(II)至式(I)化合物,包括加入式(II)化合物与介质,介质和缓冲剂,介质和溶剂的结合,或介质以及缓冲液和溶剂的混合物微生物,最好是法氏红球菌ATCC No.202210或真菌分离白色念珠菌ATCC No.74487得到的混合物,分离出式(I)的羟基化合物,是描述。式(I)的化合物是血清胆固醇降低剂。

著录项

  • 公开/公告号CA2367289C

    专利类型

  • 公开/公告日2008-02-12

    原文格式PDF

  • 申请/专利权人 SCHERING CORPORATION;

    申请/专利号CA19992367289

  • 发明设计人 HOMANN MICHAEL J.;PREVITE EDWARD;

    申请日1999-04-05

  • 分类号C12P17/10;C07D205/08;

  • 国家 CA

  • 入库时间 2022-08-21 20:03:56

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号